
Pancreatic Cancer Diabetes Drug Cases Consolidated
Incretin mimetic drugs allegedly linked to an increase in pancreatic cancer have had lawsuits consolidated into one MDL in California.
Incretin mimetic drugs allegedly linked to an increase in pancreatic cancer have had lawsuits consolidated into one MDL in California.
Fresenius, the drug manufacturer, has received multiple warnings this year from the FDA about conditions in some of its worldwide plants.
Babolat is facing a proposed class action over its use of tennis stars to endorse rackets - but has asked for a dismissal, claiming the case lacks any grounds.
US Airways' motion to dismiss a class action brought by frequent fliers has been denied.
Iovate's been hit with a class action lawsuit over its muscle growth capsules, which may in fact not work as intended.
Another company's been hit with an unpaid internship lawsuit - this time Bad Boy Entertainment.
The National Labor Relations Board has shot down a Florida university's arbitration agreement, declaring it unlawful.
Anthem Blue Cross has been accused of violating California law by capping coverage for eating disorders.
Bard's second vaginal mesh bellwether trial has ended quickly - with a surprise settlement.
ClassAction.org explains what bellwether trials actually are.